TSC2 c.4066G>A ;(p.G1356S)

Variant ID: 16-2134289-G-A

NM_000548.3(TSC2):c.4066G>A;(p.G1356S)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Chu, Ying-Hsia YH; Wirth, Lori J LJ; Farahani, Alexander A AA; Nosé, Vânia V; Faquin, William C WC; Dias-Santagata, Dora D; Sadow, Peter M PM
Publication Date: 2020-12

Variant appearance in text: TSC2: Gly1356Ser
PubMed Link: 32737449
Variant Present in the following documents:
  • Main text
  • nihms-1613364.pdf
View BVdb publication page



Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma.

Thyroid : Official Journal Of The American Thyroid Association
Dias-Santagata, Dora D; Lennerz, Jochen K JK; Sadow, Peter M PM; Frazier, Ryan P RP; Govinda Raju, Sandya S; Henry, Dahlia D; Chung, Trisha T; Kherani, Jennifer J; Rothenberg, S Michael SM; Wirth, Lori J LJ
Publication Date: 2020-09

Variant appearance in text: TSC2: 4066G>A; Gly1356Ser
PubMed Link: 32292131
Variant Present in the following documents:
  • Main text
  • thy.2019.0477.pdf
View BVdb publication page